Pneumonia as a viral complication or secondary bacterial infection in a pediatric measles? A case report
Main Article Content
Keywords
measles, pneumonia, neutrophil-lymphocyte Ratio,, pediatric
Abstract
Background: Measles is a highly contagious acute viral infection worldwide. Pneumonia is one of the major respiratory complications associated with measles and remains a leading cause of mortality. Pneumonia in measles may occur because of primary viral complications or secondary bacterial infection.
Case Presentation: A three-year-old girl presented with fever, generalized erythematous rash, conjunctival injection, cough, coryza, and shortness of breath. Physical examination revealed erythematous papules across the body, bilateral lung rhonchi, Koplik spots, and hyperemic conjunctivae. Complete blood count showed a normal white blood cell count with neutrophilia. The patient was diagnosed with measles-associated pneumonia and treated with vitamin A supplementation, antibiotics, and supportive care. She was hospitalized for five days with progressive improvement in respiratory problems and skin rash. Pneumonia in measles may develop from initial viral complications or measles-induced immunosuppression, predisposing individuals to secondary bacterial infection. In this case, an increased neutrophil-to-lymphocyte ratio was observed, which may reflect an inflammatory response and raise the suspicion of possible secondary bacterial infection. However, neutrophil to lymphocyte ratio is a non-specific marker that can also be elevated in severe viral infections, systemic inflammation, physiological stress, and corticosteroid exposure. Therefore, its interpretation should be made cautiously and in conjunction with other clinical findings.
Conclusion: The neutrophil to lymphocyte ratio is a simple and accessible laboratory parameter that may support clinical assessment but cannot independently confirm bacterial infection. Comprehensive assessment involving clinical, laboratory, and radiological findings is essential to support therapeutic decision-making in pediatric patients with measles-associated pneumonia.
Downloads
References
2. Turaiche M, Grigoras ML, Bratosin F, Bogdan I, Bota AV, Cerbu B, et al. Disease Progression, Clinical Features, and Risk Factors for Pneumonia in Unvaccinated Children and Adolescents with Measles: A Re-Emerging Disease in Romania. Int J Environ Res Public Health. 2022;19(20):13165. doi:10.3390/ijerph192013165.
3. Kemenkes Republik Indonesia. KLB Campak Meningkat, Kemenkes Ingatkan Pentingnya Imunisasi Lengkap [Internet]. 2025. [Cited 2026 February 12th]. [Available from: https://kemkes.go.id/id/klb-campak-meningkat-kemenkes-ingatkan-pentingnya-imunisasi-lengkap].
4. Misin A, Antonello RM, Di Bella S, Campisciano G, Zanotta N, Giacobbe DR, et al. Measles: An Overview of a Re-Emerging Disease in Children and Immunocompromised Patients. Microorganisms. 2020;8(2):276. doi:10.3390/microorganisms8020276.
5. Noor T, Aslam AZ, Bhatti MA, Rizwan S, Ali W. Prevalence and Outcome of Pneumonia in Children with Measles. PJMHS. 2019;13(2):216–218.
6. Lakshmanan M, Kumar S, Shashidhara S, Kini P, Aroor S, Mundkur S, et al. Neutrophil-lymphocyte ratio as a point-of-care marker for predicting bacterial etiology in pediatric community-acquired Pneumonia : A comparative analysis with C -reactive protein. Clin Epidemiol Glob Heal. 2025;35(102148):1–6. doi:10.1016/j.cegh.2025.102148.
7. Setyoningrum RA, Lestari SR, Sari RK, Visuddho V. White Blood Cell Count and Neutrophil-Lymphocyte Ratio in Children with Complicated and Uncomplicated Pneumonia. J Ilmu Medis Indones. 2024;4(1):1–7. doi:10.35912/jimi.v4i1.3560.
8. World Health Organization. Measles [Internet]. Geneva: World Health Organization; 2025. [Cited 2026 February 11th]. [Available from: https://www.who.int/news-room/fact-sheets/detail/measles].
9. Kaithathara S, Islam AW, Aasim S, Nasir S. Comprehensive Review of Measles : Latest Outbreak Trends , Clinical Manifestations , and Therapeutic Approaches. Int J Heal Sci Res. 2025;15(7):75–85. doi:10.52403/ijhsr.20250709.
10. IDAI. Jadwal Imunisasi Anak Usia 0-18 Tahun, Rekomendasi Ikatan Dokter Anak Indonesia tahun 2024 [Internet]. 2024 [Cited 2026 February 11th]. [Available from: https://www.idai.or.id/professional-resources/rekomendasi/jadwal-imunisasi-anak-usia-0-18-tahun].
11. Indani L, Prakoso I. Hubungan Antara Pemberian Imunisasi Campak dengan Kejadian Campak di Provinsi Daerah Khusus Ibukota Jakarta. Media Gizi Kesmas. 2022;11(1):130–136. doi:10.20473/mgk.v11i1.2022.130-136.
12. Husada D, Kusdwijono, Puspitasari D, Kartina L, Basuki PS, Ismoedijanto. An evaluation of the clinical features of measles virus infection for diagnosis in children within a limited resources setting. BMC Pediatr. 2020;20(1):5. doi:10.1186/s12887-020-1908-6.
13. Khongthaw JL. A review on measles and its risk factors. Int J Health Sci (Qassim). 2022;6(3):7750–7. doi:10.53730/ijhs.v6nS3.7820.
14. Bester JC. Measles and Measles Vaccination: A Review. JAMA Pediatr. 2016;170(12):1209-1215. doi:10.1001/jamapediatrics.2016.1787.
15. Rota PA, Moss WJ, Takeda M, de Swart RL, Thompson KM, Goodson JL. Measles. Nat Rev Dis Primers. 2016;2:16049. doi:10.1038/nrdp.2016.49.
16. Özel A, İlbegi EN, Yuce S, Semerci S, Tosun V, Erol M, et al. Predictive value of clinical findings and complete blood count parameters for measles diagnosis in pediatric patients : A retrospective cross-sectional study. Zeynep Kamil Med J. 2025;56(2):98–105. doi:10.14744/zkmj.2025.68889.
17. Lo Vecchio A, Krzysztofiak A, Montagnani C, Valentini P, Rossi N, Garazzino S, et al. Complications and risk factors for severe outcome in children with measles. Arch Dis Child. 2020;105(9):896-899. doi:10.1136/archdischild-2018-315290.
18. Tuncay SA, Akkoc G, Yilmaz S, Parlak B, Erdemli PC, Isik AD. Epidemic management in a measles outbreak in 2023 , the return of vaccine- preventable diseases : A single center , retrospective observational study. Asian Pac J Trop Med. 2024;17(3):110–118. doi:10.4103/apjtm.apjtm_687_23.
19. Griffin DE. Measles immunity and immunosuppression. Curr Opin Virol. 2021;46:9-14. doi:10.1016/j.coviro.2020.08.002.
20. Albarello F, Cristofaro M, Busi Rizzi E, Giancola ML, Nicastri E, Schininà V. Pulmonary measles disease: old and new imaging tools. Radiol Med. 2018;123(12):935-943. doi:10.1007/s11547-018-0919-y.
21. Buonacera A, Stancanelli B, Colaci M, Malatino L. Neutrophil to Lymphocyte Ratio: An Emerging Marker of the Relationships between the Immune System and Diseases. Int J Mol Sci. 2022;23(7):3636. doi:10.3390/ijms23073636.
22. Handoyo, Purniti NPS, Putra IGNS, Suwarba IGNM, Karyana IPG, Pratiwi IGAE. Neutrophil to Lymphocyte Ratio, Monocyte to Lymphocyte Ratio, Platelet to Lymphocyte Ratio as Predictor of Outcome in Children with Community Acquired Pneumonia. Am J Pediatr. 2022;8(3):191–195. doi:10.11648/j.ajp.20220803.18.
23. Anoun J, Ajmi M, Riahi S, Dhaha Y, Mbarki D, Ben Hassine I, et al. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in bacterial infections: contributions to diagnostic strategies in a tertiary care hospital in Tunisia. F1000Res. 2024;13:978. doi:10.12688/f1000research.146952.2.
24. Hussain I, Sunitha R, Mannu A. Neutrophil to Lymphocyte Ratio, Monocyte to Lymphocyte Ratio, Platelet to Lymphocyte Ratio as Predictors of Outcome in Children with Lower Respiratory Tract Infection. J Chem Health Risks. 2025;15(3):1296-1301.
25. Lakshmanan M, Kumar S, Shashidhara S, Kini P, Aroor S, Mundkur S, Bhat YR, Moras K. Neutrophil-lymphocyte ratio as a point-of-care marker for predicting bacterial etiology in pediatric community-acquired pneumonia: a comparative analysis with C-reactive protein. Clin Epidemiol Glob Health. 2025;35:102148. doi:10.1016/j.cegh.2025.102148.
26. Vassallo M, Derollez M, Veaute MH, Clement N, Fabre R, Lotte L, et al. The Neutrophil/Lymphocyte Ratio Was Identified as a Marker of Severe Influenza During the 2024-2025 Outbreak in France. Infect Dis Rep. 2025;17(5):127. doi:10.3390/idr17050127.
27. Yontar G, Mutlu EA. Neutrophil-to-lymphocyte, platelet-to-lymphocyte ratios and systemic immune-inflammation index in patients with post-traumatic stress disorder. BMC Psychiatry. 2024;24(1):966. doi:10.1186/s12888-024-06439-y.
28. Arwas N, Shvartzman SU, Goldbart A, Bari R, Hazan I, Horev A, et al. Elevated Neutrophil-to-Lymphocyte Ratio Is Associated with Severe Asthma Exacerbation in Children. J Clin Med. 2023;12(9):3312. doi:10.3390/jcm12093312.
29. Pengurus Pusat Ikatan Dokter Anak Indonesia. Rekomendasi Ikatan Dokter Anak Indonesia: Tata Laksana Campak. No. 07/PP IDAI/SR/1/2023. Jakarta: Ikatan Dokter Anak Indonesia; 2023.
30. Halim RG. Campak pada anak. Cermin Dunia Kedokteran. 2016;43(3):186-189. doi:10.55175/cdk.v43i3.31.
31. Kholishoh SN, Munir Z, Tauriana S. Tindakan terapi kolaborasi inhalasi untuk pasien bronkopneumonia dengan ketidakefektifan bersihan jalan napas diruang PICU RSUD Sidoarjo. TRILOGI J Ilmu Teknol Kesehatan Hum. 2024;5(1):94-104. doi:10.33650/trilogi.v5i1.7652.
32. Caraffa E, Mascia C, Ciardi MR, Lichtner M, Ajassa C, Del Borgo C, et al. Steroid use in measles: A retrospective cohort study during the 2017 outbreak in tertiary referral center, Rome and Latina, Italy. J Infect Chemother. 2024;30(3):201-207. doi:10.1016/j.jiac.2023.10.001.
33. Alanazi A, Otayn B, Al Fawaz TS. Severe measles-related pneumonia in children treated with steroid. J Pediatr Infect Dis. 2020;15(6):312-313. doi:10.1055/s-0040-1709149.
34. Rupp ME, Schwartz ML, Bechard DE. Measles pneumonia. Treatment of a near-fatal case with corticosteroids and vitamin A. Chest. 1993;103(5):1625-1626. doi:10.1378/chest.103.5.1625.